Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open‐label, randomized‐controlled FPG GOAL trial

The optimal fasting blood glucose (FBG) target of achieving HbA1c less than 7.0% in type 2 diabetes (T2D) patients remains controversial. This open‐label trial randomized (1:3:3) 947 adults with uncontrolled T2D (HbA1c >7% to ≤10.5%) who were using one to three oral antidiabetic drugs to achieve...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Wenying, Ma, Jianhua, Yuan, Guoyue, Li, Ling, Zhang, Min, Lu, Yibing, Ye, Xinhua, Song, Weihong, Liu, Ming, Wu, Jun, Chen, Riqiu, Li, Yunguang, Zhang, Xia, Cui, Nan, Yang, Jinkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772047/
https://www.ncbi.nlm.nih.gov/pubmed/30938035
http://dx.doi.org/10.1111/dom.13733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772047/
https://www.ncbi.nlm.nih.gov/pubmed/30938035
http://dx.doi.org/10.1111/dom.13733

Ejemplares similares